Ftse Mib
33.353,53
-0,42%
DAX
19.390,56
0,44%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.388,63
0,35%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NanoVibronix Inc (NAOV) NanoVibronix Inc (NAOV) Notizie

NAOV

NanoVibronix (NAOV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NAOV
DataOraFonteTitoloSimboloCompagnia
22/11/202422:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
14/11/202423:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NAOVNanoVibronix Inc
14/11/202421:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
12/11/202414:00Business WireNanoVibronix Provides Business UpdateNASDAQ:NAOVNanoVibronix Inc
29/10/202421:29Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NAOVNanoVibronix Inc
29/10/202421:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NAOVNanoVibronix Inc
29/10/202421:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NAOVNanoVibronix Inc
09/10/202414:30Business WireNanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in GermanyNASDAQ:NAOVNanoVibronix Inc
23/09/202414:30Business WireNanoVibronix Signs Letter of Intent with Potential New DistributorNASDAQ:NAOVNanoVibronix Inc
21/08/202414:30Business WireNanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
22/05/202414:30Business WireNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
16/05/202414:30Business WireNanoVibronix Issues Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
14/05/202414:30Business WireNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldNASDAQ:NAOVNanoVibronix Inc
01/05/202414:00Business WireNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract AwardNASDAQ:NAOVNanoVibronix Inc
28/03/202413:30Business WireNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldNASDAQ:NAOVNanoVibronix Inc
26/02/202423:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
14/02/202421:45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NAOVNanoVibronix Inc
06/12/202315:00Business WireNanoVibronix Featured in Your Bladder Health MagazineNASDAQ:NAOVNanoVibronix Inc
04/12/202315:00Business WireNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNASDAQ:NAOVNanoVibronix Inc
28/11/202315:00Business WireNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
21/11/202314:30Business WireNanoVibronix Regains Nasdaq ComplianceNASDAQ:NAOVNanoVibronix Inc
14/11/202314:30Business WireNanoVibronix Issues Letter to ShareholdersNASDAQ:NAOVNanoVibronix Inc
07/11/202314:30Business WireNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1NASDAQ:NAOVNanoVibronix Inc
27/09/202314:00Business WireNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffNASDAQ:NAOVNanoVibronix Inc
22/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAOVNanoVibronix Inc
21/09/202316:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NAOVNanoVibronix Inc
21/09/202316:25Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:NAOVNanoVibronix Inc
13/09/202322:45Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NAOVNanoVibronix Inc
12/09/202322:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
06/09/202314:30Business WireNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingNASDAQ:NAOVNanoVibronix Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NAOV

La tua Cronologia

BIT
UCG
Unicredit
BIT
BAMI
Banco BPM
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
ENI
Eni
BIT
TEN
Tenaris
BIT
CPR
Davide Campari
BIT
BC
Brunello Cucinelli
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network